Series B Valuation Multiple - What Investors Are Paying Right Now

The Number Everyone Quotes Is Wrong

Founders preparing for a Series B keep hearing things like "we're valued at 10x ARR" or "the market trades at 15x." Both numbers are incomplete. Your Series B valuation multiple depends entirely on which bucket you fall into - and there are now three very different buckets.

Here is what the data shows, broken down by sector and growth profile.

The Three Buckets Shaping Series B Multiples Right Now

The market has split hard. Bucket one is AI-native infrastructure. Bucket two is high-growth SaaS. Bucket three is everything else.

AI-native companies are raising Series B rounds at 20-35x forward ARR on median, with top-end outliers well beyond that. The practical shorthand for AI-native deals: take your NTM ARR estimate, apply a 20-35x multiple, and that is your pre-money valuation range before negotiation. At the very top end of the market, recent venture data shows late-stage AI rounds at roughly 25.8x median revenue multiples, with category-defining AI startups in gen AI and LLM development often seeing 40x-50x revenue multiples.

Traditional SaaS companies with strong metrics sit in a different range entirely. Private SaaS companies typically raise at 8-20x ARR at Series B, depending on growth rate, net revenue retention, and category. The working shorthand per Value Add VC: for SaaS, apply a 12-18x multiple to NTM ARR to get your pre-money valuation range before negotiation.

Slower-growth SaaS - sub-50% growth, mediocre retention - sits in a much more compressed band. At sub-50% growth, 4-6x ARR is more realistic even today. If growth drops below 15%, the valuation framework changes: buyers move to EBITDA-based valuations, typically 8-12x EBITDA. The company is priced as a cash flow asset, not a growth asset.

What a "Normal" Series B Looks Like Right Now

Strip away the AI outliers and the floor cases. The median tells a clearer story.

According to Carta's State of Private Markets, the median pre-money Series B valuation was $118.9M for primary rounds and $142.4M for bridge rounds in Q3 . This represented a significant year-over-year increase from $102.8M for primary rounds and $80.8M for bridge rounds in Q3 .

The average Series B in is $28M on a $130M post-money valuation, with AI companies commanding $40M+. Dilution has gotten better for founders: the biggest drop in came at Series B, where median dilution fell from about 15% to 12.9%.

There is a catch, though. The median company that raised a Series B round in Q1 had waited 2.8 years since their Series A - the longest median interval on record. Valuations are up. Deal counts are down. The bar to get in the room has risen materially.

How the Step-Up Multiple Works - and Why It Matters

The step-up multiple is a separate number from your ARR multiple. It measures how much your valuation grew from Series A to Series B. Investors track it closely because it tells them whether the company is compounding as expected.

Between the start of 2019 and Q3 2022, the median step-up multiple at Series B landed between 2.71x and 3.43x for 15 consecutive quarters. The median Series B step-up multiple has fallen below 2.4x in five consecutive quarters.

This matters enormously if you raised a big Series A at peak valuations. Series B is where the post-2021 repricing has been most painful for companies that raised inflated Series A valuations. If you raised a $100M post-money Series A and have grown to $8M ARR at 70% YoY growth, you are looking at a flat or down round. That is not a failure - it is arithmetic.

Carta's data made this concrete: a startup that raised seed funding at a $10 million valuation and hit the median step-up multiples at each stage in Q4 2023 would reach a Series C valuation of $87 million. The same startup using median step-up multiples from Q4 2022 would have been valued at nearly $120 million. That $33M difference comes from market timing.

The Single Biggest Lever: Net Revenue Retention

Founders often ask which metric matters most for their Series B multiple. The data is consistent on this point.

Net revenue retention is the single biggest lever on the multiple. Companies with 130%+ NRR can command the top of the range. Companies at 90% NRR are fighting uphill.

The gap is enormous. Two identical-ARR companies can receive an $80M difference in Series B valuation because one had 140% NRR and the other had 95%. Retention is the math.

Growth is the second variable. According to SaaS Capital's survey of over 1,000 private B2B SaaS companies, the median growth rate is 25%. However, companies growing above 40% annually often receive premium multiples in the 8x-10x range, while those with low-teens growth and negative margins tend to sit in the low-to-mid single digits.

The Rule of 40 is becoming the single-number scorecard VCs use to filter. The Rule of 40 has a direct impact on valuations. In Q4 , each 10-point improvement in this metric was linked to about a 1.1x increase in EV/Revenue multiples, up sharply from 0.8x in Q1. This shows how strongly investors now focus on operational efficiency.

Size Changes Your Multiple - More Than Most Founders See Coming

The "size premium" is one of the most underappreciated multipliers in Series B valuation conversations.

If your company is at $5 million or $10 million in ARR, your multiple will be several points lower than a company at $50 million or $100 million in ARR. Generally, for every $20 million increase in ARR, you gain a point or two on your revenue multiple.

Early-stage or sub-$5M ARR companies often clear in low-to-mid single-digit EV/ARR. Growth-stage companies at $20M+ ARR see mid to high single digits, with healthcare and fintech often toward the upper end when retention and margins are strong.

The spread at the top versus the bottom of the market has also widened. While SaaS valuations in have returned to the "low normal" level seen in 2016-2017 on average, today the highs are higher, the lows are lower, and the long tail stretches further right. It is a "rich get richer" valuation environment, and merely being a SaaS company is no longer a ticket to premium ARR multiples.

AI vs. SaaS: The Multiple Gap Is Not Closing

If you have any AI story, you are operating in a separate market.

AI fundraising medians sit at roughly 25-30x EV/Revenue, while public SaaS trades closer to 6x EV/Revenue. That is a 4x-5x premium for the AI label, and not all AI stories deserve it.

The premium is concentrated at the infrastructure and model layer. AI valuation multiples remain highest for LLM vendors and infrastructure, while applied niches like PropTech and HR Tech trade closer to SaaS benchmarks. LLM vendors carry the strongest multiples. Data intelligence and infrastructure follow. Applied niches sit closer to SaaS benchmarks.

For AI Series B deals specifically: at every stage from Series A onward, AI startups raised larger rounds and garnered higher valuations than their non-AI counterparts in . At Series A, the median AI valuation was 38% higher than the median non-AI valuation. Later stages show larger differences still.

One practical note: seed and Series A AI multiples remain stretched on potential, while later stages compress as scale, efficiency, and profitability increasingly matter. As growth slows, AI companies get measured on the same Rule of 40 math as everyone else.

Private vs. Public: The Discount You Should Expect

Founders often anchor to public SaaS multiples and wonder why their Series B feels lower. The discount is structural - not a negotiating failure.

Private SaaS companies trade at roughly a 30-50% discount to public peers at equivalent growth rates. The public SaaS median EV/NTM Revenue in early is approximately 6-8x. A private company growing at the same rate would typically raise at 4-6x ARR, with illiquidity premium, execution risk, and shorter track record driving the difference.

High-growth private companies at Series B get a premium over their public counterparts - because they are growing faster. Public SaaS multiples as of Q1 sit around 7-9x NTM revenue for the median public software company. Private companies at Series B get a growth premium - typically 1.5-2x the public comparable - because they are growing faster than anything public. That premium compresses quickly if growth slows.

This is why the public comp anchor is useful but incomplete. A public company growing at 15% gets a 7x multiple. A private company at Series B growing at 120% deserves a higher multiple - the growth rate justifies it, because no public company is growing at that rate anymore.

What Founders Miss When Calculating Their Multiple

I see it constantly - founders locked in on ARR and growth rate. Investors are also watching three things founders often underweight.

Customer concentration. If your largest customer is 20% of ARR, your multiple compresses. The loss of a single concentrated customer could devastate the business, which buyers factor into valuations through lower multiples or earnout structures. A commonly cited rule of thumb: no single customer should represent more than 10% of your revenue.

Gross margin. High gross margins tell investors the unit economics are clean. Higher-valued SaaS firms typically operate in large, expanding markets, have low churn, high net revenue retention, and efficient customer acquisition strategies. Low gross margins - under 60% - signal either a services-heavy model or pricing problems, both of which depress multiples.

Sector. Currently, companies in high-growth areas like AI, data analytics, advanced applications, edge computing, and cybersecurity are much more likely to receive higher multiples. Vertical SaaS in adjacent categories like HR tech or property tech often trades closer to general SaaS benchmarks regardless of growth rate.

Working Backwards from a Target Valuation

Here is how investors arrive at a Series B number in practice. It is not mystical.

Series B valuations are set almost entirely on forward ARR multiples - specifically, your projected ARR twelve months out multiplied by a comparable public SaaS or AI company multiple, then discounted for stage risk and illiquidity. The practical shorthand: take your NTM ARR estimate, apply a 12-18x multiple for SaaS or 20-35x for AI-native, and that is your pre-money valuation range before negotiation.

Walk through the math concretely. A SaaS company at $8M current ARR growing at 80% YoY projects $14.4M in NTM ARR. Apply a 15x multiple (strong SaaS, decent retention) and the pre-money is roughly $216M. Apply a 10x multiple (slower growth, median retention) and you are at $144M. The $72M difference is not negotiating room - it is metric performance.

Investors also check that number against comparable stage deals. Every Series B deal I've reviewed expects $3-10M ARR, depending on sector and growth rate. AI infrastructure companies can sometimes raise below $3M ARR if growth is explosive. SaaS companies below $5M ARR face a tough Series B environment unless net revenue retention exceeds 120% and growth is above 80% YoY.

What "Recurring Revenue" Does to Your Multiple Outside Venture

The multiple logic does not only apply to venture-backed Series B rounds. The same fundamental principle - recurring revenue deserves a higher multiple than one-time revenue - shows up across the entire private market.

One operator who runs a services business noted an instructive comparison: an agency selling $1M in annual contracts can expect roughly 0.7x revenue at exit. Switch that same revenue to a monthly recurring SaaS model and the multiple can reach 36x on the right MRR base. Find a strategic buyer for a software company with even modest recurring revenue and the outcome changes dramatically - one case showed $30K per month in recurring revenue translating into an $10M+ exit with the right strategic acquirer.

This is why the recurring revenue multiple matters beyond the pitch deck. Scalable businesses command higher multiples than stuck ones. In today's market, merely having a SaaS model is no longer a ticket to premium ARR multiples. But having durable, expanding recurring revenue is still the closest thing to a guaranteed multiple uplift that exists in private markets.

How to Move Your Multiple Before You Go to Market

The six to twelve months before your Series B are where the multiple is won or lost. Here is what moves the needle.

Improve NRR first. If your NRR is below 100%, you are losing revenue from existing customers. Fix the product, fix the pricing, fix the customer success motion. Going from 95% to 110% NRR is likely worth more to your valuation than doubling your new logo count.

Push growth rate above 80% YoY. To get to a clean Series B, you need $5-10M ARR, growth of 80-120% YoY, and a clear path to rule-of-40 economics within two years. Below 80%, you are negotiating from weakness. Above 100%, investors compete for the deal.

Reduce customer concentration before the process starts. If one customer is 25% of ARR, add two more anchor accounts at similar size before going out. Do not walk into diligence with a concentration problem you have not addressed.

Build the data room before you need it. By the time you reach your Series B round, investors expect long-since established bookkeeping systems and GAAP accounting. Be ready to provide your income statement, balance sheet, cash flow statement, a detailed cap table, and a summary of key KPIs like ARR, growth rate, and CAC. Slow diligence kills deals - especially when investors are competitive for a round.

If you want outside perspective on what is moving the needle in your specific market, operators who have been through this process can be more useful than bankers. Learn about Galadon Gold - direct coaching from operators who have built and sold businesses, not theory from people who have only advised on the outside.

The Down Round Trap - and How Founders Are Avoiding It

A prior round valuation you cannot step up from will sink your Series B before it starts.

The hangover from the market reset that occurred in 2022 is over. Less than 14% of all new fundings in Q4 were down rounds, the lowest rate in the past three years. That is good news. But it required companies to either grow through their old valuations or wait longer.

Startups have now either raised multiple rounds since the valuation climate began to shift, or they have achieved enough growth in the past three years to again justify a valuation increase - in many cases with the aid of new AI-powered tools and efficiencies.

The practical lesson: if your prior round valuation was set at peak multiples, your job is to grow revenue fast enough that your current ARR times today's multiple exceeds what you raised at. That is the only way out of a potential down round - grow into the old number. Flat rounds with good structure are infinitely better than down rounds with bad optics.

What the Data Tells You to Do Right Now

The Series B multiple market is working again. Valuations are up. Dilution is down. The market is concentrated in fewer, higher-quality deals, and a great Series B outperforms an average one by a wider margin than it used to.

If your NRR is above 120%, your growth is above 80%, and your ARR is heading toward $10M, you are in the top quartile of Series B candidates. The data supports a 15-20x forward ARR multiple for SaaS, potentially higher if there is a credible AI narrative attached.

If you are below those thresholds, the work is not to go raise - it is to fix the metrics first. Position before you go to market. The 6 to 12 months before a raise are where multiples are won or lost.

Finding the right investors for your sector matters just as much as the metrics. Knowing which firms are actively writing Series B checks in your vertical - who just closed a fund, who has portfolio companies that need your category - shifts your position at the table. Try ScraperCity free to search B2B contacts by title, company, and industry - useful when you are building your investor outreach list and need to find the right partners at target firms.

FAQs